| Income Statement |
| Operating Expenses | 24.38M |
|
| Research and Development Expense | 13.97M |
| Selling, General and Administrative Expense | 10.41M |
| Operating Income | -24.38M |
| Net Income | -23.69M |
| Net Income Common Stock | -23.69M |
| Net Income Common Stock (USD) | -23.69M |
| Consolidated Income | -23.69M |
| Earnings per Basic Share | -1.06 |
| Earnings per Basic Share (USD) | -1.06 |
| Earnings per Diluted Share | -1.06 |
| Earning Before Interest & Taxes (EBIT) | -23.69M |
| Earning Before Interest & Taxes (USD) | -23.69M |
| Weighted Average Shares | 22.45M |
| Weighted Average Shares Diluted | 22.45M |
| Balance Sheet |
| Cash and Equivalents | 20.21M |
| Cash and Equivalents (USD) | 20.21M |
| Investments | 52.41M |
| Investments Current | 52.41M |
| Current Assets | 73.65M |
| Property, Plant & Equipment Net | 97.00K |
| Total Assets | 73.74M |
| Current Liabilities | 7.77M |
| Total Liabilities | 7.77M |
| Accumulated Retained Earnings (Deficit) | -296.92M |
| Accumulated Other Comprehensive Income | -32.00K |
| Shareholders Equity | 65.98M |
| Shareholders Equity (USD) | 65.98M |
| Assets Non-Current | 97.00K |
| Trade and Non-Trade Payables | 5.00M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 7.49M |
| Net Cash Flow from Financing | 73.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.17M |
| Capital Expenditure | -38.00K |
| Issuance (Purchase) of Equity Shares | 73.00K |
| Net Cash Flow from Investing | 23.07M |
| Net Cash Flow - Investment Acquisitions and Disposals | 23.11M |
| Net Cash Flow from Operations | -20.97M |
| Share Based Compensation | 3.22M |